Investor caution is advised as Suzhou Zelgen Biopharmaceutic...
Investor caution is advised as Suzhou Zelgen Biopharmaceuticals' high P/S and less than stellar revenue forecasts could indicate a potential downturn in share price.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000026380caa80b1ec.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment